Akebia Therapeutics | AKBA - 普通股股本



金融业
股票价格
USD
资产
USD 376.57M
现金及等价物
USD 184.84M
销售成本
USD 10.34M
流动资产
USD 252.96M
流动负债
USD 162.94M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 32.61M
销售毛利
USD 47.28M
债务利息支出
4.83M
贷款资金
USD 48.25M
市值
USD 316M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 15.61M
贸易债权人
USD 21.19M
应收帐款人
USD 47.03M


普通股股本 更改 日
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Akebia Therapeutics USD 265.42M 199K 2025-12
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amgen USD 540M 1000K 2026-03
Ardelyx USD 244.35M 1.38M 2025-12
Astellas Pharma JPY 1.79B 81K 2026-03
AstraZeneca USD 1.55B 73K 2026-03
Bayer EUR 982.42M 0 2025-12
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Celltrion KRW 218.78M 1.5M 2025-09
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Exelixis USD 262.48M 5.61M 2025-12
Fresenius Medical Care EUR 279.29M 10.56M 2025-12
GlaxoSmithKline GBP 4.05B 20.6M 2026-03
Ionis Pharmaceuticals USD 165.9M 3.93M 2026-03
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 1.74M 2025-12
Kangmei Pharma CNY 13.83B 34.97M 2025-09
Karyopharm Therapeutics USD 18.31M 18.3M 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pharma Mar EUR 17.36M 0 2026-03
Prothena USD 53.83M 3K 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Qiagen NV USD 216.56M 284.67K 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Sarepta Therapeutics USD 104.96M 196K 2025-12
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03